Blood Transfusion

High-Dose Epoetin Alfa Regimen Optimally Reduces Need Following Total Hip Arthroplasty

Published in Blood Weekly, February 1st, 2001

A high-dose regimen of the hamster-derived glycoprotein epoetin alfa is the best way to prevent the need for allogeneic blood transfusion during hip joint repair surgery, researchers in Canada say.

"The optimum regimen of epoetin alfa for prevention of allogeneic blood transfusion is unknown," according to B.G. Feagan and colleagues at the John P. Robarts Research Institute in Ontario, Canada. So, they conducted a study in patients undergoing hip arthroplasty to pursue this question.

Writing in the Annals of Internal Medicine, the researchers described the results of their randomized, double-blind study, which compared the prophylactic...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2001-02-01)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry